Top

Wits RHI

Awards & Recognition

View all

Professor Sinead Delany-Moretlwe Elected to ASSAf

Professor Sinead Delany-Moretlwe, Director of Research at Wits RHI, has been elected as a member of the Academy of Science…

Read more

2026 NRF Lifetime Achievement Award: A Lifetime of Science. A Legacy of Impact

Professor Helen Rees has received the 2026 NRF Lifetime Achievement Award, recognising a distinguished career advancing health research, public health…

Read more

2026 JIAS Impact Award

Professor Sinead Delany-Moretlwe, Wits RHI Director: Research, received the 2026 Journal of the International AIDS Society (JIAS) Impact Award at…

Read more

20 Leaders Shaping Health Across Africa

Professor Helen Rees, Executive Director of Wits RHI, has been named among 20 Leaders Shaping Health Across Africa by Meridian…

Read more

Global Impact

View all

U.S. FDA approves first generic injectable lenacapavir for HIV prevention

A major milestone in expanding access to HIV prevention. The first generic version of long-acting injectable lenacapavir has received US…

Read more

Unitaid Investment: Taking Long-Acting HIV Prevention to Scale

A new Unitaid investment will support Wits RHI and partners to help countries introduce long-acting HIV prevention and generate evidence…

Read more

Professor Sinead Delany-Moretlwe Appointed to WHO STI Technical Advisory Group

Professor Sinead Delany-Moretlwe, Wits RHI Director: Research, has been appointed to the World Health Organization (WHO) Technical Advisory Group on…

Read more

Professor Helen Rees Appointed Chair of IVI Board

Professor Helen Rees, Wits RHI Executive Director has been appointed Chair of the International Vaccine Institute Board of Trustees, where…

Read more

Research Breakthrough

View all

Landmark HPV Study: Landmark Evidence for Cervical Cancer Prevention

A Wits RHI-led study provides the first population-level evidence globally that a national HPV vaccination programme can be highly effective…

Read more

Highly effective prevention drug arrives in South Africa, which has world’s highest HIV burden

Dr Nkosi Ndlovu describes the twice-yearly injectable as a “groundbreaking finding” amid national efforts to expand access to a highly…

Read more

ENABLE: Rethinking HIV Treatment for Infants

Launched in March 2026, the ENABLE project is exploring whether broadly neutralising antibodies can enhance HIV treatment and improve early…

Read more

Clinical Research

View all

IMPAACT 2023 Informs FDA Approval of Dolutegravir for Neonates

Wits RHI’s Maternal and Child Health, through Shandukani CRS, was one of 15 sites in South Africa, Thailand and the…

Read more

M72 TB Vaccine: A New Hope for TB Prevention

Wits RHI is contributing to the landmark Phase 3 M72/AS01E TB vaccine trial, advancing research towards a new generation of…

Read more

Beatrix Study: Maternal Vaccine to Prevent Group B Streptococcus in Infants

The Phase 3 Beatrix study is evaluating a Group B Streptococcus vaccine administered during pregnancy, including safety and whether vaccination…

Read more

Pandemic Preparedness

View all

Climate Change and Emerging Infectious Diseases

Wits RHI has highlighted the implications of climate change for diseases including malaria, dengue, yellow fever, chikungunya and cholera, alongside…

Read more

African Leadership for Pandemic Preparedness

Professor Helen Rees co-chairs the WHO Poxvirus CORC alongside Prof Jean-Jacques Muyembe of the DRC. The initiative brings research networks…

Read more

Global Mpox Research: Preparing for the Next Pandemic

Wits RHI is co-leading global research through the WHO Collaborative Open Research Consortia to accelerate work on mpox diagnostics, vaccines…

Read more

Wits RHI Stories

As the largest and most renowned research institute affiliated with the Faculty of Health Sciences at the University of the Witwatersrand (Wits), Wits RHI stands at the forefront of cutting-edge research and innovation. Our dedicated team of experts is committed to advancing health sciences through groundbreaking studies, impactful programs, and a relentless pursuit of excellence. Explore our stories to discover the transformative work we do and the remarkable people driving our mission forward.